Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC; the
Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer,
tobacco regulation and cessation, and patient navigators; and matters under consideration by the Joint Select Committee on Deficit Reduction. Legislation includes H. Con. Res. 34, establishing the budget for the US Government for FY 2012; S. 1599, legislation including draft House text of legislation making appropriations for L-HHS FY 12; H.R. 2055 and S. 3671,
Consolidated Appropriations Act of 2012.
Duration: September 15, 2006
to
November 30, 2011
General Issues: Budget/Appropriations , Health Issues , Tobacco , Medicare/Medicaid , Medical/Disease Research/Clinical Labs
Spending: about $320,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2006: House of Representatives, U.S. Senate
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2011
American Cancer Society, High Plains Division, Inc. in-house lobbying effort was terminated on Jan. 19, 2012
Original Filing: 300444916.xml
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC; the
Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer,
tobacco regulation and cessation, and patient navigators; and matters under consideration by the Joint Select Committee on Deficit Reduction. Legislation includes H. Con. Res. 34, establishing the budget for the US Government for FY 2012; S. 1599, legislation including draft House text of legislation making appropriations for L-HHS FY 12; H.R. 2055 and S. 3671,
Consolidated Appropriations Act of 2012.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2011.
Original Filing: 300424923.xml
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC; the
Prevention & Public Health Fund; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, and patient navigators; and matters under consideration by the Joint Select Committee on Deficit Reduction. Legislation includes H. Con. Res. 34, establishing the budget for the US Government for FY 2012; S. 1599, draft House text of legislation making appropriationsfor L-HHS FY 12; and S. 365, the Budget Control Act of 2011.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on July 20, 2011.
Original Filing: 300402871.xml
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC and for the Prevention & Public Health Fund, the Affordable Care Act provisions, breast and cervical programs, colorectal cancer programs, tobacco regulation & cessation programs, patient navigator programs, and international health programs, and H. Con. Res. 34, establishing the budget for the U.S. Government for FY 2012.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on April 19, 2011.
Original Filing: 300370049.xml
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for the Prevention & Public Health Fund, the Affordable Care Act provisions, breast and cervical programs, colorectal cancer programs, tobacco regulation & cessation programs, and patient navigator programs, including S.3686, the Senate Labor-HHS appropriations for FY11; each of the continuing resolutions making appropriations for FY11; H.R.1473 making remaining appropriations for FY11; and H. Con. Res. 34,establishing the budget for the U.S. Government for FY 2012.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2010
In Q4, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on Jan. 20, 2011.
Original Filing: 300352803.xml
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical
programs, colorectal cancer programs, tobacco regulation & cessation programs, patient navigator programs, including S.3686, the Senate Labor-HHS appropriations for FY11, and Senate Amendment to H.3081, H.J. Res.101, H.J.
Res.105 and H.3082, the 1st, 2nd, 3rd, and 4th Continuing Appropriations Act, 2011.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to health disparities, health care reform, preventative care, quality of life, federal health care programs, and cancer, including H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.717, and the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2010
In Q3, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2010.
Original Filing: 300325160.xml
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical
programs, colorectal cancer programs, and patient navigator programs, including S.3686, the Senate Labor-HHS appropriations for
FY11, and the comparable unnamed House bill.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
The prevention and early detection of cancer as it relates to the implementation of provisions enacted as part of P.L.111-148, the Patient Protection and Affordable Care Act of 2010
2nd Quarter, 2010
In Q2, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on July 16, 2010.
Original Filing: 300288851.xml
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, and patient navigator programs, including H. Con. Res. 85 and S. Con. Res. 13, the House & Senate Budget Resolution and Labor-HHS appropriations for FY11, as yet not introduced.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2010
In Q1, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on April 19, 2010.
Original Filing: 300265331.xml
Lobbying Issues
Issues related to health insurance reform, health disparities, federal health care programs, cancer, and wellness, including H.R. 3590, the Patient Protection & Affordable Care Act and H.R. 4872, the Health Care & Education Reconciliation Act of 2010, the health care reform bills.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, and patient navigator programs, to be included in legislation as yet un-numbered.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2009
In Q4, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on Jan. 20, 2010.
Original Filing: 300245733.xml
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, and patient navigator programs, H.R. 3293 Labor-HHS Appropriations for FY10.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to health insurance reform, health disparities, federal health care programs, cancer, and wellness, including H.R. 1189, the Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 3962, the Affordable Health Care for America Act, and H.R. 3590, the Senate's legislative vehicle for health care reform.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2009
In Q3, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2009.
Original Filing: 300221497.xml
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, and patient navigator programs, H.R. 3293 Labor-HHS Appropriations for FY10.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to health insurance reform, health disparities, federal health care programs, cancer, and wellness, including H.R. 1189, the Colorectal Cancer Prevention, Early Detection & Treatment Act.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on July 20, 2009.
Original Filing: 300192729.xml
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical cancer programs, colorectal cancer programs, and patient navigator programs; H.Con. Res. 85, House Budget Resolution, and S. Con. Res. 13, Senate Budget Resolution; and Labor-HHS Appropriations for FY10.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to tobacco product regulation; H.R. 1256 & S. 982, the Family Smoking Prevention and Tobacco Control Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to health disparities, federal health care programs, cancer, nutrition, and wellness, including the following legislation: H.R. 756 & S. 660, National Pain Care Policy Act; H.R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; and S. 717, the 21st Century Cancer ALERT Act.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on April 20, 2009.
Original Filing: 300164136.xml
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs, colorectal cancer programs, and patient navigator programs, H. Con. Res. 85, House Budget Resolution, and S. Con. Res. 13, Senate Budget Resolution, National Cancer Fund legislation, H.R. 1, The American Recovery and Reinvestment Act of 2009, and H.R. 1105, Omnibus appropriations legislation for FY09
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to smoking cessation, tobacco taxes and product regulation, including H.R. 1256, Family Smoking Prevention and Tobacco Control Act, and tobacco tax aspects of H.R. 2, the SCHIP legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to health disparities, federal health care programs, cancer nutrition and wellness, including the following legislation: H.R. 756 and S. 660, the National Pain Care Policy Act; H.R. 1189, the Colorectal Cancer Prevention, Early Detection, and Treatment Act; S. 717, the 21st Century Cancer ALERT Act. Issues related to access to care, including health care reform and non-specific legislative advocacy.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2008
In Q4, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on Jan. 16, 2009.
Original Filing: 300125053.xml
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical
programs and patient navigator programs, including H.R. 2642, Supplemental appropriations; S.3230 making FY09 appropriations for Labor, Health & Human Services; HR 6791, the National Cancer Fund Act; and assorted economic stimulus legislative proposals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to smoking cessation, tobacco taxes and product regulation, including S. 625, H.R. 1108, Family Smoking Prevention
and Tobacco Control Act.
Lobbying Issues
Issues related to health disparities, federal health care programs, and cancer, including H.R. 2994, National Pain Care Policy Act; and H.R. 1738, Colorectal Cancer Prevention, Early Detection & Treatment Act
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
In Q3, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on Oct. 17, 2008.
Original Filing: 300097383.xml
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical
programs and patient navigator programs, H. Con. Res. 312, House Budget Resolution, and S. Con. Res. 70, Senate Budget
Resolution, Supplemental appropriations H.R. 2642, S.3230 making FY09 appropriations for Labor, Health & Human Services, and
HR 6791, the National Cancer Fund Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to smoking cessation, tobacco taxes and product regulation, including S. 625, H.R. 1108, Family Smoking Prevention
and Tobacco Control Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1738, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 400 & H.R. 2851 Michelle's Law Act; Issues related to access to care, including healthcare reform and non-specific legislative advocacy.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on July 20, 2008.
Original Filing: 300076346.xml
Lobbying Issues
Issues related to smoking cessation, tobacco taxes and product regulation, including S. 625, H.R. 1108, Family Smoking Prevention
and Tobacco Control Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical
programs and patient navigator programs, H. Con. Res. 312, House Budget Resolution, and S. Con. Res. 70, Senate Budget
Resolution, Supplemental appropriations H.R. 2642, and House and Senate unnumbered appropriations bills for Labor, Health &
Human Services.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1738, Colorectal Cancer Prevention, Early Detection & Treatment Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 3042, The
Medicare Early Detection of Cancer Promotion Act.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
In Q1, American Cancer Society, High Plains Division, Inc. had in-house lobbyists. The report was filed on April 21, 2008.
Original Filing: 300051697.xml
Lobbying Issues
Federal budget and appropriations for cancer research and programs, including federal appropriations for breast and cervical programs and patient navigator programs, H. Con. Res. 312, House Budget Resolution, and S. Con. Res. 70, Senate Budget Resolution.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to smoking cessation and product regulation, including S. 625, H.R. 1108, the Family Smoking Prevention and Tobacco Control Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues related to health disparities, federal health care programs, and cancer, including H.R. 1738, the Colorectal Cancer Prevention, Early Detection & Treatment Act
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2006
American Cancer Society, High Plains Division, Inc. filed a lobbying registration on Feb. 8, 2007 for in-house lobbying efforts, effective Sept. 15, 2006.
Original Filing: 100052939.xml
Issue(s) they said they’d lobby about: Federal appropriations for cancer research and programs, including HR 3010, Labor, Health and Human Services, and Education appropriations; Issues related to health disparities and federal health care programs, including S 1687/HR 5472, National Breast and Cervical Cancer Early Detection Program and Reauthorization Act; Anticipate lobbying on FDA regulation of tobacco, as well as continued lobbying on new legislation related to issues mentioned above. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...